Delivery Order SPE2DB22D1103-SPE2DB25FTKC0
Award Date
4/10/25
Potential Completion Date
4/11/25
Potential Value
$3.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $37,494.09 firm fixed-price delivery order is for the supply of Ozempic, a diabetes medication, and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides...
This federal contract award, valued at $14,581.38, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of Ozempic, a diabetes medication, with an ultimate completion date of April 23, 2025. The contract is a Firm Fixed Price Delivery Order, without any set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Ozempic, a diabetes medication. The $44,956.33 firm fixed-price delivery order contract has a completion date of May 15, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive global...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,879.98 firm fixed-price delivery order is for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml, a diabetes medication. The contract has an ultimate completion date of May 7, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $21,817.70 firm fixed-price delivery order is for the supply of Ozempic, a medication used to treat diabetes. The contract has an ultimate completion date of May 15, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $42,496.74 firm fixed-price delivery order contract is for the supply of Ozempic, a diabetes medication, with a performance period ending in April 2025. The award is not set-aside and represents an order under AmerisourceBergen's broader $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,345.86 Firm Fixed Price Delivery Order is for the supply of Ozempic 2 mg/dose (8 mg/3 ml) 3 ml, a diabetes medication. The contract has an ultimate completion date of May 12, 2025 and is not set aside. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award from the Defense Logistics Agency (DLA) was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,523.88 firm fixed-price delivery order is for the supply of Ozempic, a medication used to manage diabetes. The contract has a period of performance through December 9, 2024 and was not designated as a set-aside requirement. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,117.85 delivery order contract is for the supply of Ozempic, a medication used to treat diabetes. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of April 22, 2025. AmerisourceBergen holds a substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,114.10 firm fixed-price delivery order is for the supply of Ozempic, a prescription medication used to treat type 2 diabetes. The contract has an ultimate completion date of April 22, 2025 and is not set aside for any specific business category. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery...